Spectracef

Spectracef Brand names, Spectracef Analogs

Spectracef Brand Names Mixture

No information avaliable

Spectracef Chemical_Formula

C₂₅H₂₈N₆O₇S₃

Spectracef RX_link

http://www.rxlist.com/cgi/generic3/spectracef.htm

Spectracef fda sheet

Spectracef FDA

Spectracef msds (material safety sheet)

Spectracef Synthesis Reference

No information avaliable

Spectracef Molecular Weight

620.724 g/mol

Spectracef Melting Point

127 - 129 ^oC

Spectracef H₂O Solubility

Soluble at levels equal to < 0.1 mg/mL.

Spectracef State

Solid

Spectracef LogP

2.721

Spectracef Dosage Forms

Tablets (200mg) for oral administration.

Spectracef Indication

For the treatment of mild to moderate infections in adults and adolescents (12 years of age or older) which are caused by susceptible strains of microorganisms in acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, pharyngitis/tonsillitis, and uncomplicated skin and skin-structure infections.

Spectracef Pharmacology

Cefditoren pivoxil is a prodrug which is hydrolyzed by esterases during absorption, and the drug is distributed in the circulating blood as active cefditoren. Cefditoren is a cephalosporin with antibacterial activity against gram-positive and gram-negative pathogens. Cefditoren is effective against Staphylococcus aureus (methicillin-susceptible strains, including b-lactamase-producing strains), penicillin-susceptible strains of Staphylococcus aureus and Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae (including b-lactamase-producing strains), Haemophilus parainfluenzae (including b-lactamase-producing strains), Moraxella catarrhalis (including b-lactamase-producing strains), Streptococcus agalactiae, Streptococcus Groups C and G, and Streptococcus, viridans group (penicillin-susceptible and -intermediate strains).

Spectracef Absorption

Following oral administration, cefditoren pivoxil is absorbed from the gastrointestinal tract and hydrolyzed to cefditoren by esterases. Under fasting conditions, the estimated absolute bioavailability of cefditoren pivoxil is approximately 14%. The absolute bioavailability of cefditoren pivoxil administered with a low fat meal (693 cal, 14 g fat, 122 g carb, 23 g protein) is 16.1 ± 3.0%.

Spectracef side effects and Toxicity

Information on cefditoren pivoxil overdosage in humans is not available. However, with other b-lactam antibiotics, adverse effects following overdosage have included nausea, vomiting, epigastric distress, diarrhea, and convulsions. In acute animal toxicity studies, cefditoren pivoxil when tested at the limit oral doses of 5100 mg/kg in rats and up to 2000 mg/kg in dogs did not exhibit any health effects of concern.

Spectracef Patient Information